Slide background




Some Industrial Chemicals: IARC Volume115 (2018)

ID 7017 | | Visite: 1503 | Documenti Sicurezza EntiPermalink: https://www.certifico.com/id/7017

Temi: Chemicals , Safety

IARC Volume115

Some Industrial Chemicals: IARC Volume115 (2018)

This one-hundred-and-fifteenth volume of the IARC Monographs contains evaluations of the carcinogenic hazard to humans of seven industrial chemicals to which workers or the general population are or can be potentially exposed.

n. Agent CAS IARC
1. N,N-dimethylformamide 68-12-2  Group 2A
2. 2-mercaptobenzothiazole 149-30-4 Group 2A 
3. hydrazine 302-01-2 Group 2A
4. tetrabromobisphenol A 79-94-7 Group 2A
5. 1-bromopropane 106-94-5 Group 2B
6. 3-chloro-2-methylpropene 563-47-3 Group 2B
7. N,N-dimethyl-p-toluidine  99-97-8 Group 2B 

All seven agents were accorded high or medium priority for evaluation in the IARC Monographs programme by an Advisory Group that met in 2014 (Straif et al., 2014). 3-Chloro-2-methylpropene was evaluated previously in Volume 63 of the IARC Monographs (IARC, 1995) as not classifiable as to its carcinogenicity to humans (Group 3). Hydrazine was evaluated previously as possibly carcinogenic to humans (Group 2B) and N,N-dimethylformamide as not classifiable as to its carcinogenicity to humans (Group 3) in Volume 71 of the IARC Monographs (IARC, 1999).
Since the previous evaluations, new data have become available. A summary of the findings of this volume appears in The Lancet Oncology (Grosse et al., 2016).

High production volume chemicals and exposure measurement data
Four “high production volume” chemicals (N,N-dimethyl-p-toluidine, 2-mercaptobenzothiazole, tetrabromobisphenol A, and N,N-dimethylformamide) were evaluated. The Working Group noted that for two of these (N,N-dimethyl-p-toluidine and 2-mercaptobenzothiazole) no data on exposure measurement were available in occupational settings or the general population.
Data on exposure measurement were also lacking for two other chemicals evaluated in the present volume (3-chloro-2-methylpropene and
hydrazine).

Isoniazid
Hydrazine is a metabolite of isonicotinic acid hydrazide (isoniazid), which was evaluated in Supplement 7 of the IARC Monographs as not
classifiable as to its carcinogenicity to humans (Group 3) (IARC, 1987). Data on hydrazine and its metabolites from studies on isoniazid and isoniazid metabolites are included in Section 4 of the monograph on hydrazine, but isoniazid was not re-evaluated.

IARC 2018

_______

The agent is described according to the wording of one of the following categories, and the designated group is given. The categorization
of an agent is a matter of scientific judgement that reflects the strength of the evidence derived from studies in humans and in experimental animals and from mechanistic and other relevant data.

Group 1: The agent is carcinogenic to humans.
This category is used when there is sufficient evidence of carcinogenicity in humans. Exceptionally, an agent may be placed in this category when evidence of carcinogenicity in humans is less than sufficient but there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the agent acts through a relevant mechanism of carcinogenicity. Group 2. This category includes agents for which, at one extreme, the degree of evidence of carcinogenicity in humans is almost sufficient, as well as those for which, at the other extreme, there are no human data but for which there is evidence of carcinogenicity in experimental animals. Agents are assigned to either Group 2A (probably carcinogenic to humans) or Group 2B (possibly carcinogenic to humans) on the basis of epidemiological and experimental evidence of carcinogenicity and mechanistic and other relevant data. The terms probably carcinogenic and possibly carcinogenic have no quantitative significance and are used simply as descriptors of different levels of evidence of human carcinogenicity, with probably carcinogenic signifying a higher level of evidence than possibly carcinogenic.

Group 2A: The agent is probably carcinogenic to humans.
This category is used when there is limited evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals. In some cases, an agent may be classified in this category when there is inadequate evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals and strong evidence that the carcinogenesis is mediated by a mechanism that also operates in humans. Exceptionally, an agent may be classified in this category solely on the basis of limited evidence of carcinogenicity in humans. An agent may be assigned to this category if it clearly belongs, based on mechanistic considerations, to a class of agents for which one or more members have been classified in Group 1 or Group 2A.

Group 2B: The agent is possibly carcinogenic to humans.
This category is used for agents for which there is limited evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals. It may also be used when there is inadequate evidence of carcinogenicity in humans but there is sufficient evidence of carcinogenicity in experimental animals. In some instances, an agent for which there is inadequate evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals together with supporting evidence from mechanistic and other relevant data may be placed in this group. An agent may be classified in this category solely on the basis of strong evidence from mechanistic and other relevant data.

Group 3: The agent is not classifiable as to its carcinogenicity to humans.
This category is used most commonly for agents for which the evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals. Exceptionally, agents for which the evidence of carcinogenicity is inadequate in humans but sufficient in experimental animals may be placed in this category when there is strong evidence that the mechanism of carcinogenicity in experimental animals does not operate in humans. Agents that do not fall into any other group are also placed in this category. An evaluation in Group 3 is not a determination of non-carcinogenicity or overall safety. It often means that further research is needed, Preamble 31 especially when exposures are widespread or the cancer data are consistent with differing interpretations.

Group 4: The agent is probably not carcinogenic to humans.
This category is used for agents for which there is evidence suggesting lack of carcinogenicity in humans and in experimental animals. In some instances, agents for which there is inadequate evidence of carcinogenicity in humans but evidence suggesting lack of carcinogenicity in experimental animals, consistently and strongly supported by a broad range of mechanistic and other relevant data, may be classified in this group.

Scarica questo file (07. N,N-Dimethyl-p-toluidine - CAS 99-97-8.pdf)07. N,N-Dimethyl-p-toluidine - CAS 99-97-8IARC Volume115 (2018)EN319 kB(1291 Downloads)
Scarica questo file (06. 3-Chloro-2-methylpropene - CAS 563-47-3.pdf)06. 3-Chloro-2-methylpropene - CAS 563-47-3 EN231 kB(496 Downloads)
Scarica questo file (05. 1-Bromopropane - CAS 106-94-5.pdf)05. 1-Bromopropane - CAS 106-94-5IARC Volume115 (2018)EN523 kB(395 Downloads)
Scarica questo file (04. Tetrabromobisphenol A - CAS 79-94-7.pdf)04. Tetrabromobisphenol A - CAS 79-94-7IARC Volume115 (2018)EN744 kB(488 Downloads)
Scarica questo file (03. Hydrazine - CAS 302-01-2.pdf)03. Hydrazine - CAS 302-01-2IARC Volume115 (2018)EN683 kB(371 Downloads)
Scarica questo file (02. 2-mercaptobenzothiazole - CAS 149-30-4.pdf)02. 2-mercaptobenzothiazole - CAS 149-30-4IARC Volume115 (2018)EN393 kB(1225 Downloads)
Scarica questo file (01. N,N-Dimethylformamide - CAS 68-12-2.pdf)01. N,N-Dimethylformamide - CAS 68-12-2IARC Volume115 (2018)EN784 kB(357 Downloads)
Scarica questo file (IARC Volume115.pdf)IARC Volume115IARC 2018IT4056 kB(332 Downloads)

Tags: Chemicals Safety

Ultimi archiviati Sicurezza

Legge 21 novembre 2000 n  353
Mag 11, 2021 79

Legge 21 novembre 2000 n. 353

Legge 21 novembre 2000 n. 353 Legge-quadro in materia di incendi boschivi. (GU n.280 del 30-11-2000) Entrata in vigore della legge: 1-12-2000 Aggiornamenti all'atto 10/09/2001 DECRETO-LEGGE 7 settembre 2001, n. 343 (in G.U. 10/09/2001, n.210) convertito con modificazioni dalla L. 9 novembre 2001,… Leggi tutto
Reiserimento persona disabilita daq lavoro per il DL
Mag 10, 2021 86

Reinserimento persone con disabilità da lavoro | INAIL 2021

Reinserimento e integrazione lavorativa delle persone con disabilità da lavoro I due opuscoli, realizzati in occasione della nuova campagna di comunicazione “Con Inail, ricomincio dal mio lavoro, sul reinserimento lavorativo delle persone con disabilità da lavoro, contengono una sintesi delle… Leggi tutto
Nota 5 maggio 2021 n  688
Mag 08, 2021 188

Ministero dell’Istruzione nota 5 maggio 2021 n. 688

Ministero dell’Istruzione nota 5 maggio 2021 n. 688 Denuncia di infortunio per il personale scolastico positivo al Covid-19 Copertura assicurativa per studenti e insegnanti per infortuni accaduti durante la DAD o la DDI per la parte non in presenza OGGETTO: Denuncia di infortunio per il personale… Leggi tutto
ECDC 05 May 2021
Mag 07, 2021 97

Use of rapid antigen detection tests for SARS-CoV-2 in occupational settings

Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings ECDC / EU-OSHA, Rapporto tecnico, 5 maggio 2021 This document outlines the public health considerations for the use of rapid antigen detection tests (RADTs, including self-test RADTs… Leggi tutto
Dati INAIL 4 2021
Mag 05, 2021 121

Dati Inail n. 4 Aprile 2021 | Contagi COVID -19 industria alimentare

Dati Inail n. 4 Aprile 2021 | Contagi COVID -19 industria alimentare Covid-19 e industria alimentare, sei contagi su 10 nel trimestre ottobre-dicembre 2020 A questo settore produttivo, che non ha subito chiusure o restrizioni legate all’emergenza sanitaria perché rientra tra quelli considerati… Leggi tutto

Più letti Sicurezza